Treating Equivalent Cases Differently: A Comparative Analysis of Substance Use Disorder and Type 2 Diabetes in Norwegian Treatment Guidelines

Overview

Journal J Eval Clin Pract

Specialties General Medicine
Health Services

Date 2022 Apr 29

PMID 35484825

Authors

Fredrik D Moe

Henrik Berg

Affiliations

Soon will be listed here.

Abstract

Background: Substance use disorder (SUD) is often understood as a chronic illness.

Aims: This paper investigates whether SUD is treated as a chronic illness.

Method: To this aim, we have used World Health Organizations (WHO's) definition of chronic illness to conduct a comparative analysis of SUD and type 2 diabetes (T2D), which is another chronic illness.

Results: When analysing Norwegian treatment guidelines, we found that only the T2D guideline reflects the WHO's conceptualization of chronic illnesses. We argue that this discrepancy implies that SUD is understood as a moral and legal problem, while T2D is conceptualized as a somatic illness. We discuss how social, political and historical conditions of the possibility for understanding SUD are interwoven with normative presumptions about the clinician, patient, treatment guidelines and drug policies in a way that may impede the development of continuing care.

Conclusion: The paper concludes that the delivery of treatment services is inequitable as SUD is not treated as a chronic illness.

Citing Articles

The interdependence of substance use, satisfaction with life, and psychological distress: a dynamic structural equation model analysis.

Moe F, Erga A, Bjornestad J, Dettweiler U Front Psychiatry. 2024; 15:1288551.

PMID: 38404472 PMC: 10884273. DOI: 10.3389/fpsyt.2024.1288551.

Beyond Diagnosis: Preliminary Study of Impact on Children and Parents in Neurodevelopmental Disorders and Juvenile Idiopathic Arthritis-Associated Uveitis.

Palmieri R, Albano V, Guerriero S, Craig F, La Torre F, Filoni S Diagnostics (Basel). 2024; 14(3).

PMID: 38337791 PMC: 10855410. DOI: 10.3390/diagnostics14030275.

Philosophy and the clinic: Stigma, respect and shame.

Loughlin M, Dolezal L, Hutchinson P, Subramani S, Milani R, Lafarge C J Eval Clin Pract. 2022; 28(5):705-710.

PMID: 36053567 PMC: 9826409. DOI: 10.1111/jep.13755.

Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines.

Moe F, Berg H J Eval Clin Pract. 2022; 28(5):721-728.

PMID: 35484825 PMC: 9790317. DOI: 10.1111/jep.13693.

References

Moe F, Berg H . Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines. J Eval Clin Pract. 2022; 28(5):721-728. PMC: 9790317. DOI: 10.1111/jep.13693. View

Stumvoll M, Goldstein B, van Haeften T . Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365(9467):1333-46. DOI: 10.1016/S0140-6736(05)61032-X. View

Mennis J, Stahler G, Mason M . Risky Substance Use Environments and Addiction: A New Frontier for Environmental Justice Research. Int J Environ Res Public Health. 2016; 13(6). PMC: 4924064. DOI: 10.3390/ijerph13060607. View

Hyman S, Malenka R, Nestler E . Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci. 2006; 29:565-98. DOI: 10.1146/annurev.neuro.29.051605.113009. View

Kendler K, Karkowski L, Neale M, Prescott C . Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry. 2000; 57(3):261-9. DOI: 10.1001/archpsyc.57.3.261. View

McKay J . Impact of Continuing Care on Recovery From Substance Use Disorder. Alcohol Res. 2021; 41(1):01. PMC: 7813220. DOI: 10.35946/arcr.v41.1.01. View

Tiffany S, Friedman L, Greenfield S, Hasin D, Jackson R . Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2011; 107(4):709-18. PMC: 3257402. DOI: 10.1111/j.1360-0443.2011.03581.x. View

Heyman G . Quitting drugs: quantitative and qualitative features. Annu Rev Clin Psychol. 2013; 9:29-59. DOI: 10.1146/annurev-clinpsy-032511-143041. View

Heather N . Q: Is Addiction a Brain Disease or a Moral Failing? A: Neither. Neuroethics. 2017; 10(1):115-124. PMC: 5486515. DOI: 10.1007/s12152-016-9289-0. View

10.

Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J . Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992; 35(11):1060-7. DOI: 10.1007/BF02221682. View

11.

Moe F, Moltu C, McKay J, Nesvag S, Bjornestad J . Is the relapse concept in studies of substance use disorders a 'one size fits all' concept? A systematic review of relapse operationalisations. Drug Alcohol Rev. 2021; 41(4):743-758. DOI: 10.1111/dar.13401. View

12.

McLellan A, Lewis D, OBrien C, KLEBER H . Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000; 284(13):1689-95. DOI: 10.1001/jama.284.13.1689. View

13.

Fulford K . Values-based practice: a new partner to evidence-based practice and a first for psychiatry?. Mens Sana Monogr. 2011; 6(1):10-21. PMC: 3190543. DOI: 10.4103/0973-1229.40565. View

14.

Borse S, Chhipa A, Sharma V, Singh D, Nivsarkar M . Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives. Med Princ Pract. 2020; 30(2):109-121. PMC: 8114074. DOI: 10.1159/000511002. View

15.

McKay J . Is there a case for extended interventions for alcohol and drug use disorders?. Addiction. 2005; 100(11):1594-610. DOI: 10.1111/j.1360-0443.2005.01208.x. View

16.

Wu L, Zhu H, Ghitza U . Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data. Drug Alcohol Depend. 2018; 192:316-323. PMC: 6358206. DOI: 10.1016/j.drugalcdep.2018.08.013. View

17.

Willemsen G, Ward K, Bell C, Christensen K, Bowden J, Dalgard C . The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium. Twin Res Hum Genet. 2015; 18(6):762-71. DOI: 10.1017/thg.2015.83. View

18.

Fuchsberger C, Flannick J, Teslovich T, Mahajan A, Agarwala V, Gaulton K . The genetic architecture of type 2 diabetes. Nature. 2016; 536(7614):41-47. PMC: 5034897. DOI: 10.1038/nature18642. View

19.

Montenegro R, Dori-Hacohen G . Morality in sugar talk: Presenting blood glucose levels in routine diabetes medical visits. Soc Sci Med. 2020; 253:112925. DOI: 10.1016/j.socscimed.2020.112925. View

20.

Broom D, Whittaker A . Controlling diabetes, controlling diabetics: moral language in the management of diabetes type 2. Soc Sci Med. 2004; 58(11):2371-82. DOI: 10.1016/j.socscimed.2003.09.002. View